These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 20702612)
1. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Kodumudi KN; Woan K; Gilvary DL; Sahakian E; Wei S; Djeu JY Clin Cancer Res; 2010 Sep; 16(18):4583-94. PubMed ID: 20702612 [TBL] [Abstract][Full Text] [Related]
2. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway. Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418 [TBL] [Abstract][Full Text] [Related]
3. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Le HK; Graham L; Cha E; Morales JK; Manjili MH; Bear HD Int Immunopharmacol; 2009 Jul; 9(7-8):900-9. PubMed ID: 19336265 [TBL] [Abstract][Full Text] [Related]
4. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice. Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068 [TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors. Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342 [TBL] [Abstract][Full Text] [Related]
7. l-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice. Cao Y; Wang Q; Du Y; Liu F; Zhang Y; Feng Y; Jin F Int Immunopharmacol; 2016 Jun; 35():7-14. PubMed ID: 27003114 [TBL] [Abstract][Full Text] [Related]
8. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response. Chakraborty P; Das S; Banerjee K; Sinha A; Roy S; Chatterjee M; Choudhuri SK Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):165-75. PubMed ID: 24611750 [TBL] [Abstract][Full Text] [Related]
9. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists. Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020 [TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice. Abe F; Dafferner AJ; Donkor M; Westphal SN; Scholar EM; Solheim JC; Singh RK; Hoke TA; Talmadge JE Cancer Immunol Immunother; 2010 Jan; 59(1):47-62. PubMed ID: 19449184 [TBL] [Abstract][Full Text] [Related]
11. Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells. Wu H; Tao N; Liu X; Li X; Tang J; Ma C; Xu X; Shao H; Hou B; Wang H; Qin Z PLoS One; 2012; 7(12):e51751. PubMed ID: 23272159 [TBL] [Abstract][Full Text] [Related]
12. Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Nagaraj S; Nelson A; Youn JI; Cheng P; Quiceno D; Gabrilovich DI Cancer Res; 2012 Feb; 72(4):928-38. PubMed ID: 22237629 [TBL] [Abstract][Full Text] [Related]
13. Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice. Lee YH; Lee YR; Park CS; Im SA; Song S; Hong JT; Whang BY; Kim K; Lee CK Int Immunopharmacol; 2014 Aug; 21(2):487-93. PubMed ID: 24957690 [TBL] [Abstract][Full Text] [Related]
14. Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Tu SP; Jin H; Shi JD; Zhu LM; Suo Y; Lu G; Liu A; Wang TC; Yang CS Cancer Prev Res (Phila); 2012 Feb; 5(2):205-15. PubMed ID: 22030090 [TBL] [Abstract][Full Text] [Related]
15. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Pan PY; Ma G; Weber KJ; Ozao-Choy J; Wang G; Yin B; Divino CM; Chen SH Cancer Res; 2010 Jan; 70(1):99-108. PubMed ID: 19996287 [TBL] [Abstract][Full Text] [Related]
16. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model. Hu Y; Liu J; Cui P; Liu T; Piao C; Xu X; Zhang Q; Xiao M; Lu Y; Liu X; Wang Y; Lu X Cell Immunol; 2020 Feb; 348():104036. PubMed ID: 31924315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]